
浏览全部资源
扫码关注微信
1.400038 重庆,陆军军医大学(第三军医大学)高原军事医学系:高原特需药品与器材研究室
2.400038 重庆,陆军军医大学(第三军医大学)高原军事医学系:高原生理学与病理学教研室
3.400038 重庆,陆军军医大学(第三军医大学)高原军事医学系:极端环境医学教育部重点实验室
[高钰琪,E-mail:gaoy66@yahoo.com GAO Yuqi, E-mail: gaoy66@yahoo.com
收稿:2021-07-23,
修回:2021-09-25,
纸质出版:2021-11-15
移动端阅览
吴启建, 张二龙, 孙滨达, 等. TLR9-JNK信号通路调控缺氧诱导大鼠肺动脉平滑肌细胞增殖[J]. 第三军医大学学报, 2021,43(21):2350-2357.
Qijian WU, Erlong ZHANG, Binda SUN, et al. TLR9-JNK signaling pathway regulates hypoxia-induced proliferation of rat pulmonary artery smooth muscle cells[J]. Journal of Third Military Medical University, 2021, 43(21): 2350-2357.
吴启建, 张二龙, 孙滨达, 等. TLR9-JNK信号通路调控缺氧诱导大鼠肺动脉平滑肌细胞增殖[J]. 第三军医大学学报, 2021,43(21):2350-2357. DOI: 10.16016/j.1000-5404.202107145.
Qijian WU, Erlong ZHANG, Binda SUN, et al. TLR9-JNK signaling pathway regulates hypoxia-induced proliferation of rat pulmonary artery smooth muscle cells[J]. Journal of Third Military Medical University, 2021, 43(21): 2350-2357. DOI: 10.16016/j.1000-5404.202107145.
目的
2
研究Toll样受体-9(toll-like receptor 9,TLR9)在缺氧诱导大鼠肺动脉平滑肌细胞(rat pulmonary artery smooth muscle cells,RPASMCs)增殖中的作用及机制。
方法
2
采用MTT、Western blot、PCR法检测RPASMCs的相对增殖水平、蛋白表达水平、mRNA转录水平。①3% O
2
,36 h处理RPASMCs,构建缺氧诱导RPASMCs增殖的细胞模型,检测细胞相对增殖水平、TLR9、磷酸化c-jun氨基末端激酶(phosphorylated c-jun N-terminal kinase,p-JNK)蛋白表达水平。②缺氧条件下分别使用小干扰RNA序列(small interfering RNA sequence,siRNA)或20 μmol/L TLR9激动剂ODN 1826敲低或活化TLR9,检测RPASMCs的细胞增殖水平和c-jun氨基末端激酶(c-jun N-terminal kinase,JNK)磷酸化水平。③缺氧时使用5 μmol/L JNK抑制剂SP600125处理RPASMCs,检测缺氧条件下细胞相对增殖水平。④缺氧时复合使用20 μmol/L TLR9激动剂ODN 1826和5 μmol/L JNK抑制剂SP600125处理RPASMCs,检测RPASMCs的JNK磷酸化水平和相对增殖水平。
结果
2
缺氧组RPASMCs的相对增殖水平[(1.30±0.07),
P
<
0.01
]
以及TLR9蛋白水平[(1.70±0.22),
P
<
0.05
]
和JNK磷酸化[(1.83±0.18),
P
<
0.01
]
都显著高于常氧组。敲低TLR9显著抑制缺氧诱导的RPASMC增殖[(0.64±0.09),
P
<
0.01
]
并减少JNK磷酸化[(0.49±0.01),
P
<
0.001
]
。TLR9激动剂显著促进RPASMCs增殖[(2.01±0.08),
P
<
0.001
]
且增加JNK的磷酸化[(2.11±0.33),
P
<
0.01
]
。JNK抑制剂抑制RPASMCs增殖[(0.70±0.06),
P
<
0.05
]
。与缺氧+TLR9激动剂组相比,缺氧+TLR9激动剂+JNK抑制剂组RPASMCs JNK磷酸化[(0.82±0.14)
vs
(1.59±0.30),
P
<
0.001
]
和相对增殖水平[(1.08±0.05)
vs
(1.35± 0.02),
P
<
0.001
]
都显著降低。
结论
2
缺氧时TLR9通过激活JNK通路促进大鼠肺动脉平滑肌细胞增殖。
Objective
2
To investigate the role and mechanism of Toll-like receptor 9 (TLR9) in hypoxia-induced proliferation of rat pulmonary artery smooth muscle cells (RPASMCs).
Methods
2
MTT assay
Western blotting and PCR were adopted to measure cell proliferation level
protein and mRNA levels of following molecules in RPASMCs. ① After RPASMCs were treated with 3% O
2
for 36 h to establish a hypoxic model
the cell proliferation and expression levels of TLR9 and phosphorylated c-jun N-terminal kinase(p-JNK) were detected at the same time. ② After TLR9 was knocked down using small interfering RNA sequence (siRNA) or activated by 20 μmol/L TLR9 agonist
ODN 1826
under hypoxia
the proliferation and p-JNK level were examined. ③RPASMCs were treated with 5 μmol/L JNK inhibitor SP600125 under hypoxia
and the proliferation was assayed. ④ Under hypoxia
20 μmol/L ODN 1826 combined with 5 μmol/L SP600125 were administered to RPASMCs
and the proliferation and level of p-JNK were measured.
Results
2
The proliferation of RPASMCs (1.30±0.07
P
<
0.01) and protein levels of TLR9 (1.70±0.22
P
<
0.05) and p-JNK (1.83±0.18
P
<
0.01) were significantly higher in the hypoxia group than the normoxia group. Knock-down of TLR9 significantly inhibited hypoxia-induced proliferation of RPASMC (0.64±0.09
P
<
0.01) and reduced the JNK phosphorylation (0.49±0.01
P
<
0.001). TLR9 agonist
ODN 1826
significantly promoted the proliferation of RPASMCs (2.01±0.08
P
<
0.001) and increased JNK phosphorylation (2.11±0.33
P
<
0.01). JNK inhibitor SP600125 inhibited the proliferation (0.70±0.06
P
<
0.05). Compared with hypoxia+TLR9 agonist group
the level of p-JNK (0.82±0.14
vs
1.59±0.30
P
<
0.001) and cell proliferation (1.08±0.05
vs
1.35±0.02
P
<
0.001) were both decreased significantly in hypoxia+TLR9 agonist+JNK inhibitor group.
Conclusion
2
TLR9 promotes the proliferation of RPASMCs by activating the JNK pathway under hypoxia.
高钰琪. 高原军事医学[M]. 重庆: 重庆出版社, 2005: 54-74.
GAO Y Q. Plateau military medicine[M]. Chongqing: Chongqing Publishing House, 2005: 54-74.
HUMBERT M, GUIGNABERT C, BONNET S, et al . Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives[J ] . Eur Respir J, 2019, 53(1): 1801887. DOI: 10.1183/13993003.01887-2018.
THENAPPAN T, ORMISTON M L, RYAN J J, et al . Pulmonary arterial hypertension: pathogenesis and clinical management[J ] . BMJ, 2018, 360: j5492. DOI: 10.1136/bmj.j5492.
DODSON M W, BROWN L M, ELLIOTT C G. Pulmonary arterial hypertension[J]. Heart Fail Clin, 2018, 14(3): 255-269. DOI: 10.1016/j.hfc.2018.02.003.
TUDER R M. Pulmonary vascular remodeling in pulmonary hypertension[J]. Cell Tissue Res, 2017, 367(3): 643-649. DOI: 10.1007/s00441-016-2539-y.
SHIMODA L A, LAURIE S S. Vascular remodeling in pulmonary hypertension[J]. J Mol Med Berlin Ger, 2013, 91(3): 297-309. DOI: 10.1007/s00109-013-0998-0.
ULRICH S, NICOLLS M R, TARASEVICIENE L, et al . Increased regulatory and decreased CD8 + cytotoxic T cells in the blood of patients with idiopathic pulmonary arterial hypertension[J ] . Respiration, 2008, 75(3): 272-280. DOI: 10.1159/000111548..
BALABANIAN K, FOUSSAT A, DORFMULLER P, et al . CX(3)C chemokine fractalkine in pulmonary arterial hypertension[J ] . Am J Respir Crit Care Med, 2002, 165(10): 1419-1425. DOI: 10.1164/rccm.2106007.
ULRICH S, TARASEVICIENE-STEWART L, HUBER L C, et al . Peripheral blood B lymphocytes derived from patients with idiopathic pulmonary arterial hypertension express a different RNA pattern compared with healthy controls: a cross sectional study[J ] . Respir Res, 2008, 9: 20. DOI: 10.1186/1465-9921-9-20.
PERROS F, DORFMULLER P, SOUZA R, et al . Dendritic cell recruitment in lesions of human and experimental pulmonary hypertension[J ] . Eur Respir J, 2007, 29(3): 462-468. DOI: 10.1183/09031936.00094706.
STACHER E, GRAHAM B B, HUNT J M, et al . Modern age pathology of pulmonary arterial hypertension[J ] . Am J Respir Crit Care Med, 2012, 186(3): 261-272. DOI: 10.1164/rccm.201201-0164OC.
罗勇军, 刘福玉, 后显华, 等. 移居高原早期中性粒细胞的线粒体形态学变化[J]. 西南国防医药, 2011, 21(1): 12-14. DOI: 10.3969/j.issn.1004-0188.2011.01.004.
LUO Y J, LIU F Y, HOU X H, et al . Early morphologic changes of neutrophil mitochondria in healthy young men after high-altitude migration[J ] . Med J Natl Defending Forces Southwest China, 2011, 21(1): 12-14. DOI: 10.3969/j.issn.1004-0188.2011.01.004.
蔡明春, 柳君泽. 大鼠缺氧过程中脑线粒体超微结构变化及形态计量学研究[J]. 高原医学杂志, 2000, 10(2): 12-14, 66.
CAI M C, LIU J Z. Study on ultrastructural changes and morphometrics of brain mitochondria during hypoxia in rats [J]. J High Alt Med, 2000, 10(2): 12-14, 66.
蔡明春, 黄庆愿, 高钰琪. 缺氧及缺氧复合运动大鼠骨骼肌线粒体功能的变化[J]. 西南国防医药, 2008, 18(4): 482-484. DOI: 10.3969/j.issn.1004-0188.2008.04.007.
CAI M C, HUANG Q Y, GAO Y Q. Effects of training in hypobaric hypoxia on rat muscle mitochondrial function[J]. Med J Natl Defending Forces Southwest China, 2008, 18(4): 482-484. DOI: 10.3969/j.issn.1004-0188.2008.04.007.
BANOTH B, CASSEL S L. Mitochondria in innate immune signaling[J]. Transl Res, 2018, 202: 52-68. DOI: 10.1016/j.trsl.2018.07.014.
ZHANG Z Y, MENG P, HAN Y J, et al . Mitochondrial DNA-LL-37 complex promotes atherosclerosis by escaping from autophagic recognition[J ] . Immunity, 2015, 43(6): 1137-1147. DOI: 10.1016/j.immuni.2015.10.018.
OKA T, HIKOSO S, YAMAGUCHI O, et al . Mitochondrial DNA that escapes from autophagy causes inflammation and heart failure[J ] . Nature, 2012, 485(7397): 251-255. DOI: 10.1038/nature10992.
MCCARTHY C G, WENCESLAU C F, GOULOPOULOU S, et al . Circulating mitochondrial DNA and Toll-like receptor 9 are associated with vascular dysfunction in spontaneously hypertensive rats[J ] . Cardiovasc Res, 2015, 107(1): 119-130. DOI: 10.1093/cvr/cvv137.
GARCIA-MARTINEZ I, SANTORO N, CHEN Y, et al . Hepatocyte mitochondrial DNA drives nonalcoholic steatohepatitis by activation of TLR9[J ] . J Clin Invest, 2016, 126(3): 859-864. DOI: 10.1172/JCI83885.
HAN S J, LI H, KIM M, et al . Kidney proximal tubular TLR9 exacerbates ischemic acute kidney injury[J ] . J Immunol, 2018, 201(3): 1073-1085. DOI: 10.4049/jimmunol.1800211.
HOLLE J U, WINDMOLLER M, LANGE C, et al . Toll-like receptor TLR2 and TLR9 ligation triggers neutrophil activation in granulomatosis with polyangiitis[J ] . Rheumatology (Oxford), 2013, 52(7): 1183-1189. DOI: 10.1093/rheumatology/kes415.
LIU Y, YAN W, TOHME S, et al . Hypoxia induced HMGB1 and mitochondrial DNA interactions mediate tumor growth in hepatocellular carcinoma through Toll-like receptor 9[J ] . J Hepatol, 2015, 63(1): 114-121. DOI: 10.1016/j.jhep.2015.02.009.
TONG J J, SUN D D, YANG C, et al . Serum starvation and thymidine double blocking achieved efficient cell cycle synchronization and altered the expression of p27, p53, bcl-2 in canine breast cancer cells[J ] . Res Vet Sci, 2016, 105: 10-14. DOI: 10.1016/j.rvsc.2016.01.008.
BAUER E M, SHAPIRO R, ZHENG H, et al . High mobility group box 1 contributes to the pathogenesis of experimental pulmonary hypertension via activation of Toll-like receptor 4[J ] . Mol Med, 2013, 18: 1509-1518. DOI: 10.2119/molmed.2012.00283.
WANG J, TIAN X T, PENG Z, et al . HMGB1/TLR4 promotes hypoxic pulmonary hypertension via suppressing BMPR2 signaling[J ] . Vascul Pharmacol, 2019, 117: 35-44. DOI: 10.1016/j.vph.2018.12.006.
FARKAS D, THOMPSON A A R, BHAGWANI A R, et al . Toll-like receptor 3 is a therapeutic target for pulmonary hypertension[J ] . Am J Respir Crit Care Med, 2019, 199(2): 199-210. DOI: 10.1164/rccm.201707-1370OC.
XIAO G, ZHUANG W, WANG T, et al . Transcriptomic analysis identifies Toll-like and Nod-like pathways and necroptosis in pulmonary arterial hypertension[J ] . J Cell Mol Med, 2020, 24(19): 11409-11421. DOI: 10.1111/jcmm.15745.
LOOMIS Z, EIGENBERGER P, REDINIUS K, et al . Hemoglobin induced cell trauma indirectly influences endothelial TLR9 activity resulting in pulmonary vascular smooth muscle cell activation[J ] . PLoS ONE, 2017, 12(2): e0171219. DOI: 10.1371/journal.pone.0171219.
ISHIKAWA T, ABE K, TAKANA-ISHIKAWA M, et al . Chronic inhibition of Toll-Like receptor 9 ameliorates pulmonary hypertension in rats[J ] . J Am Heart Assoc, 2021, 10(7): e019247. DOI: 10.1161/JAHA .120.019247.
WILSON J L, YU J, TAYLOR L, et al . Hyperplastic growth of pulmonary artery smooth muscle cells from subjects with pulmonary arterial hypertension is activated through JNK and p38 MAPK[J ] . PLoS ONE, 2015, 10(4): e0123662. DOI: 10.1371/journal.pone.0123662.
PANZHINSKIY E, ZAWADA W M, STENMARK K R, et al . Hypoxia induces unique proliferative response in adventitial fibroblasts by activating PDGFβ receptor-JNK 1 signalling[J ] . Cardiovasc Res, 2012, 95(3): 356-365. DOI: 10.1093/cvr/cvs194..
DAS M, ZAWADA W M, WEST J, et al . JNK2 regulates vascular remodeling in pulmonary hypertension[J ] . Pulm Circ, 2018, 8(3): 2045894018778156. DOI: 10.1177/2045894018778156.
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621